Americana Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.95M | Sell |
57,290
-419
| -0.7% | -$28.9K | 0.14% | 141 |
|
|
2025
Q1 | $4.01M | Buy |
57,709
+2,609
| +5% | +$181K | 0.16% | 121 |
|
|
2024
Q4 | $4.74M | Buy |
55,100
+3,169
| +6% | +$273K | 0.19% | 110 |
|
|
2024
Q3 | $6.18M | Buy |
51,931
+2,563
| +5% | +$305K | 0.42% | 68 |
|
|
2024
Q2 | $7.05M | Buy |
49,368
+1,657
| +3% | +$237K | 0.55% | 46 |
|
|
2024
Q1 | $6.13M | Buy |
47,711
+1,360
| +3% | +$175K | 0.51% | 55 |
|
|
2023
Q4 | $4.79M | Sell |
46,351
-4,871
| -10% | -$504K | 0.46% | 63 |
|
|
2023
Q3 | $4.68M | Buy |
51,222
+15,438
| +43% | +$1.41M | 0.51% | 51 |
|
|
2023
Q2 | $2.9M | Buy |
35,784
+182
| +0.5% | +$14.7K | 0.37% | 72 |
|
|
2023
Q1 | $2.83M | Sell |
35,602
-2
| -0% | -$159 | 0.45% | 67 |
|
|
2022
Q4 | $2.4M | Sell |
35,604
-298
| -0.8% | -$20.1K | 0.42% | 65 |
|
|
2022
Q3 | $1.79M | Buy |
35,902
+1,328
| +4% | +$66.1K | 0.32% | 84 |
|
|
2022
Q2 | $1.91M | Sell |
34,574
-388
| -1% | -$21.4K | 0.34% | 76 |
|
|
2022
Q1 | $276K | Buy |
+34,962
| New | +$276K | 0.08% | 187 |
|
|
2020
Q1 | – | Sell |
-1,458
| Closed | -$42K | – | 377 |
|
|
2019
Q4 | $42K | Buy |
+1,458
| New | +$42K | 0.02% | 241 |
|